Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:IVC

Invacare (IVC) Stock Price, News & Analysis

Invacare logo

About Invacare Stock (NYSE:IVC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IVC Stock News Headlines

Buckeye Trail volleyball stays perfect with key IVC victory
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
Buckeye Trail coasts past Newcomerstown for key IVC win
IL&FS Investment Managers Limited (IVC.NS)
See More Headlines

IVC Stock Analysis - Frequently Asked Questions

Invacare Co. (NYSE:IVC) issued its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invacare investors own include Pfizer (PFE), Intel (INTC), Exxon Mobil (XOM), Micron Technology (MU), Occidental Petroleum (OXY), Devon Energy (DVN) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
10/27/2021
Today
9/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:IVC
CIK
742112
Employees
3,000
Year Founded
1885

Profitability

EPS (Trailing Twelve Months)
($2.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.56 million
Net Margins
-9.99%
Pretax Margin
-9.38%
Return on Equity
-37.76%
Return on Assets
-7.18%

Debt

Debt-to-Equity Ratio
4.82
Current Ratio
1.32
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$872.46 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.77
Book Value
$5.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
37,760,000
Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:IVC) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners